(Q34569095)

English

Cytogenetics and age are major determinants of outcome in intensively treated acute myeloid leukemia patients older than 60 years: results from AMLSG trial AML HD98-B.

scientific article

Statements

Cytogenetics and age are major determinants of outcome in intensively treated acute myeloid leukemia patients older than 60 years: results from AMLSG trial AML HD98-B. (English)
Stefan Fröhling
Richard F Schlenk
Sabine Kayser
Martina Morhardt
Axel Benner
German-Austrian AML Study Group
3280-3288

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit